110 related articles for article (PubMed ID: 37578667)
1. Correction to: Epigenetic regulation of LINC01270 in breast cancer progression by mediating LAMA2 promoter methylation and MAPK signaling pathway.
Li S; Hu J; Li G; Mai H; Gao Y; Liang B; Wu H; Guo J; Duan Y
Cell Biol Toxicol; 2023 Dec; 39(6):3345. PubMed ID: 37578667
[No Abstract] [Full Text] [Related]
2. Epigenetic regulation of LINC01270 in breast cancer progression by mediating LAMA2 promoter methylation and MAPK signaling pathway.
Li S; Hu J; Li G; Mai H; Gao Y; Liang B; Wu H; Guo J; Duan Y
Cell Biol Toxicol; 2023 Aug; 39(4):1359-1375. PubMed ID: 36241925
[TBL] [Abstract][Full Text] [Related]
3. Silencing of long non-coding RNA LINC01270 inhibits esophageal cancer progression and enhances chemosensitivity to 5-fluorouracil by mediating GSTP1methylation.
Li N; Zhao Z; Miao F; Cai S; Liu P; Yu Y; Wang B
Cancer Gene Ther; 2021 May; 28(5):471-485. PubMed ID: 33199829
[TBL] [Abstract][Full Text] [Related]
4. Expression and methylation status of LAMA2 are associated with the invasiveness of nonfunctioning PitNET.
Wang RQ; Lan YL; Lou JC; Lyu YZ; Hao YC; Su QF; Ma BB; Yuan ZB; Yu ZK; Zhang HQ; Wang DS; Zhu TZ; Ding Y; Zhang N; Zhang B
Ther Adv Endocrinol Metab; 2019; 10():2042018818821296. PubMed ID: 30728939
[TBL] [Abstract][Full Text] [Related]
5. Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.
Lee S; Oh T; Chung H; Rha S; Kim C; Moon Y; Hoehn BD; Jeong D; Lee S; Kim N; Park C; Yoo M; An S
Int J Oncol; 2012 Mar; 40(3):889-98. PubMed ID: 22038115
[TBL] [Abstract][Full Text] [Related]
6. LncRNA LINC01270 aggravates the progression of gastric cancer through modulation of miR-326/EFNA3 axis.
Jiang B; Yang K; Tang C; Chen R; Wang C
Bioengineered; 2022 Apr; 13(4):8994-9005. PubMed ID: 35345980
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA LINC01270 is an onco-promotor in lung adenocarcinoma by upregulating LARP1 via sponging miR-326.
Zhang W; Cao C; Shen J; Shan S; Tong Y; Cai H; Han Z; Chai H
Bioengineered; 2022 Jun; 13(6):14472-14488. PubMed ID: 36694453
[TBL] [Abstract][Full Text] [Related]
8. Correction: Silencing of long non-coding RNA LINC01270 inhibits esophageal cancer progression and enhances chemosensitivity to 5-fluorouracil by mediating GSTP1methylation.
Li N; Zhao Z; Miao F; Cai S; Liu P; Yu Y; Wang B
Cancer Gene Ther; 2022 Aug; 29(8-9):1299-1300. PubMed ID: 35277667
[No Abstract] [Full Text] [Related]
9. Epigenetic silencing of genes enhanced by collective role of reactive oxygen species and MAPK signaling downstream ERK/Snail axis: Ectopic application of hydrogen peroxide repress CDH1 gene by enhanced DNA methyltransferase activity in human breast cancer.
Pradhan N; Parbin S; Kar S; Das L; Kirtana R; Suma Seshadri G; Sengupta D; Deb M; Kausar C; Patra SK
Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1651-1665. PubMed ID: 30954555
[TBL] [Abstract][Full Text] [Related]
10. Annexin A6 is down-regulated through promoter methylation in gastric cancer.
Wang X; Zhang S; Zhang J; Lam E; Liu X; Sun J; Feng L; Lu H; Yu J; Jin H
Am J Transl Res; 2013; 5(5):555-62. PubMed ID: 23977414
[TBL] [Abstract][Full Text] [Related]
11. The phytochemical brazilin suppress DNMT1 expression by recruiting p53 to its promoter resulting in the epigenetic restoration of p21 in MCF7cells.
Chatterjee B; Ghosh K; Swain A; Nalla KK; Ravula H; Pan A; Kanade SR
Phytomedicine; 2022 Jan; 95():153885. PubMed ID: 34920321
[TBL] [Abstract][Full Text] [Related]
12. The EZH2- H3K27me3-DNMT1 complex orchestrates epigenetic silencing of the wwc1 gene, a Hippo/YAP pathway upstream effector, in breast cancer epithelial cells.
Liu X; Li C; Zhang R; Xiao W; Niu X; Ye X; Li Z; Guo Y; Tan J; Li Y
Cell Signal; 2018 Nov; 51():243-256. PubMed ID: 30121333
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic silencing of HOPX contributes to cancer aggressiveness in breast cancer.
Kikuchi M; Katoh H; Waraya M; Tanaka Y; Ishii S; Tanaka T; Nishizawa N; Yokoi K; Minatani N; Ema A; Kosaka Y; Tanino H; Yamashita K; Watanabe M
Cancer Lett; 2017 Jan; 384():70-78. PubMed ID: 27756570
[TBL] [Abstract][Full Text] [Related]
14. LINC00858 knockdown inhibits gastric cancer cell growth and induces apoptosis through reducing WNK2 promoter methylation.
Du J; Liang Y; Li J; Zhao JM; Lin XY
Cell Oncol (Dordr); 2020 Aug; 43(4):709-723. PubMed ID: 32447640
[TBL] [Abstract][Full Text] [Related]
15. Promoter methylation induced epigenetic silencing of DAZAP2, a downstream effector of p38/MAPK pathway, in multiple myeloma cells.
Li J; Hu WX; Luo SQ; Xiong DH; Sun S; Wang YP; Bu XF; Liu J; Hu J
Cell Signal; 2019 Aug; 60():136-145. PubMed ID: 31034872
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia Drives Breast Tumor Malignancy through a TET-TNFα-p38-MAPK Signaling Axis.
Wu MZ; Chen SF; Nieh S; Benner C; Ger LP; Jan CI; Ma L; Chen CH; Hishida T; Chang HT; Lin YS; Montserrat N; Gascon P; Sancho-Martinez I; Izpisua Belmonte JC
Cancer Res; 2015 Sep; 75(18):3912-24. PubMed ID: 26294212
[TBL] [Abstract][Full Text] [Related]
17. TFPI inhibits breast cancer progression by suppressing ERK/p38 MAPK signaling pathway.
Xing M; Yang Y; Huang J; Fang Y; Jin Y; Li L; Chen X; Zhu X; Ma C
Genes Genomics; 2022 Jul; 44(7):801-812. PubMed ID: 35567715
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of the tumor suppressor C-terminal Src kinase (Csk)-binding protein (Cbp)/PAG1 is mediated by epigenetic histone modifications via the mitogen-activated protein kinase (MAPK)/phosphatidylinositol 3-kinase (PI3K) pathway.
Suzuki K; Oneyama C; Kimura H; Tajima S; Okada M
J Biol Chem; 2011 May; 286(18):15698-706. PubMed ID: 21388951
[TBL] [Abstract][Full Text] [Related]
19. A study on promoter methylation of PTEN in sporadic breast cancer patients from North India.
Siddiqui S; Akhter N; Deo SV; Shukla NK; Husain SA
Breast Cancer; 2016 Nov; 23(6):922-931. PubMed ID: 26754093
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.
Rodenhiser DI; Andrews J; Kennette W; Sadikovic B; Mendlowitz A; Tuck AB; Chambers AF
Breast Cancer Res; 2008; 10(4):R62. PubMed ID: 18638373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
